Table 5 Supplementary and/or functional tests available for PPGL genes
Type of material required | Test description | Expected results | Target gene | Target mutation type | Evidence level of test* | Refs |
---|---|---|---|---|---|---|
Tumour or leukocyte RNA | cDNA sequencing | Identification of aberrant RNA transcript | All PPGLs susceptibility genes | Splice mutations | B | |
Tumour DNA | Sequencing, MLPA, SNP array or microsatellite markers study (for copy number analysis) | Identification of LOH (by deletion or somatic mutation of the contralateral allele) | PPGLs tumour suppressor genes | All | B | |
Methylation analysis | Identification of methylation of the contralateral allele | PPGLs tumour suppressor genes | All | B | ||
Frozen tumour tissue | SDH enzymatic activity measurement | Loss of SDH enzymatic activity | SDH | All | A | |
Fumarase enzymatic activity measurement | Loss of fumarase enzymatic activity | FH | All | A | ||
Succinate concentration | Accumulation of succinate | SDH | All | B | ||
Fumarate concentration | Accumulation of fumarate | FH | All | B | ||
Metabolome profiling by HRMAS NMR spectroscopy | Accumulation of succinate | SDH | All | C | ||
FFPE tumour tissue section | SDHB/SDHD IHC | SDHB negative or SDHD positive IHC | SDH | All | A | |
SDHA IHC | SDHA negative IHC | SDHA | All | A | ||
MAX IHC | MAX negative IHC | MAX | Truncating mutations | B | ||
2-SC IHC | 2-SC positive IHC | FH | All | B | ||
In vitro assay | PC12 rat phaeochromocytoma cell-based luciferase reporter assay (mutagenesis) | Alteration of MAX regulatory effects on MYC | MAX | Missense | C | |
Endomembrane localization or subcellular distribution of expressed mutant constructs by confocal microscopy | Intracellular distribution of TMEM127 mutant | TMEM127 | Missense | C | ||
SDH cellular distribution | Loss of SDH mitochondrial localization | SDH | All | C | ||
In vivo assay | In vivo succinate detection by magnetic resonance spectroscopy | Accumulation of succinate in vivo | SDH | All | C |